Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.
Bristoyiannis G, Germanos N, Grekas D, Hatzidimitriou C, Iatrou C, Memmos D, Moutafis S, Papachristoforou K, Papadoniou A, Pappas M, Sakellariou GA, Siamopoulos KC, Sombolos K, Stamatelou K, Stathakis CP, Stavgiannoudakis G, Stratigis S, Syrganis C, Tsakiris D, Valis D, Vlahojannis JG, Vlassopoulos D.
Bristoyiannis G, et al. Among authors: valis d.
Curr Ther Res Clin Exp. 2005 May;66(3):195-211. doi: 10.1016/j.curtheres.2005.06.009.
Curr Ther Res Clin Exp. 2005.
PMID: 24672123
Free PMC article.